Parithera, an EPFL spin-off, has developed a system that lets doctors detect drug resistance in cancer patients early on, saving precious time and preventing the unnecessary use of treatments with onerous side effects.
Media properties
- Themes
- Research and Tech Transfer , Cancer, Startups and Industry, Research and Tech Transfer
- Copyright
- EPFL - Alain Herzog
- Licence
- CC0 Licence
- Shooting date
- Oct. 6, 2023
- Album
- Rapid early detection of drug resistance in cancer patients
Share on